ReVance Therapeutics Inc.
This article was originally published in Start Up
Executive Summary
After spending its first three years quietly amassing preclinical and clinical data on its pipeline for aesthetic and therapeutic dermatology, Essentia Biosystems is ready to make some noise. It has unveiled a new name, ReVance Therapeutics Inc., will soon announce some key hires, and is preparing to enter the clinic with its lead candidate, a topical, "wipe-on" form of botulinum toxin delivered with the company's proprietary technology for transporting large molecule drugs through the skin.